CRISPR Therapeutics to Present at the American Association
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating......
Kura Oncology Announces Acceptance of Two Abstracts for
– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine kinase inhibitors – SAN DIEGO, March ......
Nurix Therapeutics Announces Presentations at the American
Nurix to report additional preclinical data for its targeted BTK degraders NX-2127 and NX-5948......
Sana Biotechnology Announces the Acceptance of Four
Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene......
Cullinan Oncology to Present New Preclinical Data for
CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with advanced solid tumors. Initial......
The Lovesac Company to Announce Fourth Quarter and Fiscal
STAMFORD, Conn., March 14, 2023 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) today announced that its fourth quarter and fiscal 2023 financial......
Adamis Pharmaceuticals Schedules Fourth Quarter and Full
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily......
Ed Mylett to Inspire and Motivate as Keynote Speaker at
Find your true path with Ed Mylett at eXp Shareholder Summit, May 17-20, 2023 in Orlando, FL......
LumiraDx to Announce Fourth Quarter and Full Year 2022
LONDON, March 14, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will......
Repligen Corporation to Present at KeyBanc Life Science and
WALTHAM, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology......